Share Price and Basic Stock Data
Last Updated: February 6, 2026, 3:27 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sanginita Chemicals Ltd operates in the organic chemicals segment and has reported a market capitalization of ₹27.8 Cr. The company’s share price stood at ₹10.8, reflecting a P/BV ratio of 0.41x, indicating that the stock is trading at a discount compared to its book value. Over the last fiscal years, the company’s sales have shown fluctuations, with a notable decline from ₹197 Cr in FY 2022 to ₹149 Cr in FY 2023. However, FY 2025 is projected to recover significantly with sales expected to reach ₹230 Cr. Quarterly sales also depict variability; for instance, sales peaked at ₹61.34 Cr in September 2024 but dropped to ₹29.16 Cr by December 2024. The overall trend indicates a gradual recovery, but the company must address the volatility in sales to stabilize revenue streams moving forward.
Profitability and Efficiency Metrics
Profitability metrics for Sanginita Chemicals reveal a challenging environment, with an Operating Profit Margin (OPM) recorded at -4.03% for December 2025, indicating operational inefficiencies. The company reported an operating profit of ₹1.11 Cr in December 2022, but this figure declined significantly over the following quarters, hitting a low of ₹-1.75 Cr by December 2025. The Return on Equity (ROE) stood at a meager 1.28%, while the Return on Capital Employed (ROCE) was slightly better at 4.19%. The Interest Coverage Ratio (ICR) recorded at 2.03x suggests that the company can cover its interest obligations, but the low profitability raises concerns about long-term sustainability. The fluctuating net profit figures, with a net profit of ₹0 in FY 2023 and a loss of ₹2.78 Cr in December 2025, further underscore the need for operational improvements and cost management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sanginita Chemicals indicates a cautious financial position, with total borrowings amounting to ₹26 Cr against reserves of ₹30 Cr. The debt-to-equity ratio stood at 0.46, suggesting a moderate reliance on debt financing. The company reported total assets of ₹102 Cr and total liabilities of ₹102 Cr, indicating a balanced structure but raising concerns about its ability to leverage assets efficiently. Furthermore, the current ratio of 1.93x signals adequate liquidity to meet short-term obligations, while the quick ratio of 1.27x bolsters this assertion. However, the company’s operating performance, as reflected in its efficiency ratios, shows a cash conversion cycle of 85 days, which is relatively high and could indicate inefficiencies in managing working capital. The asset turnover ratio of 2.44% points to a decent utilization of assets, but overall financial health remains contingent on improving profitability.
Shareholding Pattern and Investor Confidence
Sanginita Chemicals’ shareholding pattern reflects significant shifts in investor confidence, particularly concerning promoter holdings, which declined from 62.47% in December 2022 to 30.00% by September 2025. This reduction in promoter stake could raise alarms among investors regarding the long-term commitment of the management. Conversely, the public shareholding increased from 37.53% to 70% over the same period, indicating growing retail investor interest. The number of shareholders rose from 9,646 in December 2022 to 16,654 by September 2025, suggesting a broadening of the investor base. However, the high public shareholding amidst declining promoter confidence could lead to volatility in stock performance. The lack of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) participation further emphasizes a need for improved corporate governance and performance metrics to attract institutional investments.
Outlook, Risks, and Final Insight
The outlook for Sanginita Chemicals hinges on its ability to stabilize revenue and enhance profitability metrics. Key strengths include a relatively low debt level and a diverse shareholder base, which may provide stability. However, significant risks persist, including fluctuating operational profitability and declining promoter confidence, which could affect long-term strategic direction. If the company can effectively manage its cost structure and improve operational efficiencies, it may witness a recovery in margins and profitability. Conversely, persistent operational challenges and market volatility could hinder growth prospects. Stakeholders must monitor the evolving financial landscape and management strategies closely, as these will be critical in determining Sanginita Chemicals’ future trajectory in the competitive organic chemicals market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 54.2 Cr. | 152 | 437/135 | 126 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 6,818 Cr. | 8,600 | 14,250/7,772 | 49.4 | 1,177 | 0.09 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 28.5 Cr. | 95.0 | 329/73.0 | 14.1 | 26.9 | 1.05 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 194 Cr. | 242 | 435/163 | 10.8 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,490.83 Cr | 1,439.78 | 54.10 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.51 | 33.82 | 35.90 | 33.41 | 29.16 | 53.04 | 56.95 | 61.34 | 61.54 | 49.85 | 45.91 | 44.10 | 43.47 |
| Expenses | 32.40 | 33.24 | 34.69 | 31.98 | 27.94 | 52.94 | 55.67 | 60.08 | 60.38 | 48.87 | 45.11 | 43.77 | 45.22 |
| Operating Profit | 1.11 | 0.58 | 1.21 | 1.43 | 1.22 | 0.10 | 1.28 | 1.26 | 1.16 | 0.98 | 0.80 | 0.33 | -1.75 |
| OPM % | 3.31% | 1.71% | 3.37% | 4.28% | 4.18% | 0.19% | 2.25% | 2.05% | 1.88% | 1.97% | 1.74% | 0.75% | -4.03% |
| Other Income | 0.05 | 0.11 | 0.07 | 0.08 | 0.25 | 0.04 | 0.04 | 0.13 | 0.08 | 0.01 | 0.37 | 0.01 | 0.00 |
| Interest | 0.63 | 0.68 | 0.66 | 0.62 | 0.66 | 0.68 | 0.64 | 0.63 | 0.58 | 0.59 | 0.53 | 0.47 | 0.49 |
| Depreciation | 0.14 | 0.14 | 0.15 | 0.16 | 0.20 | 0.24 | 0.26 | 0.47 | 0.48 | 0.47 | 0.54 | 0.56 | 0.55 |
| Profit before tax | 0.39 | -0.13 | 0.47 | 0.73 | 0.61 | -0.78 | 0.42 | 0.29 | 0.18 | -0.07 | 0.10 | -0.69 | -2.79 |
| Tax % | 23.08% | -30.77% | 25.53% | 26.03% | 26.23% | -24.36% | 26.19% | 24.14% | 27.78% | -14.29% | -10.00% | -1.45% | -0.36% |
| Net Profit | 0.29 | -0.10 | 0.35 | 0.54 | 0.46 | -0.58 | 0.31 | 0.22 | 0.14 | -0.05 | 0.11 | -0.68 | -2.78 |
| EPS in Rs | 0.11 | -0.04 | 0.14 | 0.21 | 0.18 | -0.22 | 0.12 | 0.08 | 0.05 | -0.02 | 0.04 | -0.26 | -1.07 |
Last Updated: January 10, 2026, 6:47 pm
Below is a detailed analysis of the quarterly data for Sanginita Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 43.47 Cr.. The value appears to be declining and may need further review. It has decreased from 44.10 Cr. (Sep 2025) to 43.47 Cr., marking a decrease of 0.63 Cr..
- For Expenses, as of Dec 2025, the value is 45.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.77 Cr. (Sep 2025) to 45.22 Cr., marking an increase of 1.45 Cr..
- For Operating Profit, as of Dec 2025, the value is -1.75 Cr.. The value appears to be declining and may need further review. It has decreased from 0.33 Cr. (Sep 2025) to -1.75 Cr., marking a decrease of 2.08 Cr..
- For OPM %, as of Dec 2025, the value is -4.03%. The value appears to be declining and may need further review. It has decreased from 0.75% (Sep 2025) to -4.03%, marking a decrease of 4.78%.
- For Other Income, as of Dec 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Sep 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Dec 2025, the value is 0.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.47 Cr. (Sep 2025) to 0.49 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Dec 2025, the value is 0.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.56 Cr. (Sep 2025) to 0.55 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Dec 2025, the value is -2.79 Cr.. The value appears to be declining and may need further review. It has decreased from -0.69 Cr. (Sep 2025) to -2.79 Cr., marking a decrease of 2.10 Cr..
- For Tax %, as of Dec 2025, the value is -0.36%. The value appears to be increasing, which may not be favorable. It has increased from -1.45% (Sep 2025) to -0.36%, marking an increase of 1.09%.
- For Net Profit, as of Dec 2025, the value is -2.78 Cr.. The value appears to be declining and may need further review. It has decreased from -0.68 Cr. (Sep 2025) to -2.78 Cr., marking a decrease of 2.10 Cr..
- For EPS in Rs, as of Dec 2025, the value is -1.07. The value appears to be declining and may need further review. It has decreased from -0.26 (Sep 2025) to -1.07, marking a decrease of 0.81.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 119 | 129 | 151 | 155 | 197 | 188 | 160 | 164 | 197 | 149 | 151 | 230 | 201 |
| Expenses | 114 | 124 | 147 | 150 | 189 | 178 | 151 | 160 | 195 | 145 | 147 | 225 | 198 |
| Operating Profit | 5 | 4 | 5 | 5 | 8 | 9 | 8 | 4 | 3 | 3 | 4 | 5 | 3 |
| OPM % | 4% | 3% | 3% | 3% | 4% | 5% | 5% | 2% | 1% | 2% | 3% | 2% | 2% |
| Other Income | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 2 | 5 | 5 | 4 | 1 | 0 | 1 | 1 | 1 | -0 |
| Tax % | 35% | 32% | 32% | 34% | 33% | 28% | 25% | 25% | 24% | 23% | 27% | 25% | |
| Net Profit | 1 | 1 | 1 | 1 | 3 | 4 | 3 | 1 | 0 | 0 | 1 | 1 | -0 |
| EPS in Rs | 0.68 | 0.81 | 0.87 | 0.43 | 1.33 | 1.52 | 1.30 | 0.29 | 0.14 | 0.16 | 0.30 | 0.24 | -0.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | 200.00% | 33.33% | -25.00% | -66.67% | -100.00% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | 200.00% | -166.67% | -58.33% | -41.67% | -33.33% | 100.00% |
Sanginita Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -29% |
| 3 Years: | 21% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -31% |
| 3 Years: | -22% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 1:25 pm
Balance Sheet
Last Updated: December 10, 2025, 3:21 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 26 | 26 |
| Reserves | 6 | 7 | 8 | 11 | 14 | 18 | 21 | 22 | 22 | 23 | 24 | 30 | 30 |
| Borrowings | 23 | 23 | 25 | 26 | 26 | 29 | 35 | 29 | 35 | 29 | 33 | 26 | 26 |
| Other Liabilities | 7 | 12 | 2 | 7 | 3 | 7 | 5 | 2 | 5 | 11 | 12 | 20 | 20 |
| Total Liabilities | 44 | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 80 | 86 | 102 | 102 |
| Fixed Assets | 5 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 15 | 14 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 40 | 46 | 40 | 57 | 57 | 67 | 74 | 66 | 75 | 75 | 78 | 87 | 88 |
| Total Assets | 44 | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 80 | 86 | 102 | 102 |
Below is a detailed analysis of the balance sheet data for Sanginita Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 30.00 Cr..
- For Borrowings, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 102.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 102.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 88.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 88.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 102.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 102.00 Cr..
Notably, the Reserves (30.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | -19.00 | -20.00 | -21.00 | -18.00 | -20.00 | -27.00 | -25.00 | -32.00 | -26.00 | -29.00 | -21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 86 | 64 | 96 | 66 | 62 | 89 | 65 | 46 | 63 | 64 | 58 |
| Inventory Days | 48 | 41 | 30 | 29 | 29 | 39 | 50 | 51 | 46 | 70 | 76 | 49 |
| Days Payable | 14 | 32 | 2 | 15 | 3 | 8 | 7 | 2 | 8 | 25 | 27 | 22 |
| Cash Conversion Cycle | 98 | 95 | 93 | 109 | 92 | 93 | 132 | 114 | 84 | 107 | 112 | 85 |
| Working Capital Days | 99 | 34 | 33 | 58 | 52 | 60 | 78 | 78 | 72 | 81 | 86 | 67 |
| ROCE % | 12% | 11% | 11% | 10% | 14% | 14% | 11% | 5% | 4% | 4% | 5% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.24 | 0.45 | 0.24 | 0.20 | 0.44 |
| Diluted EPS (Rs.) | 0.24 | 0.45 | 0.24 | 0.20 | 0.44 |
| Cash EPS (Rs.) | 0.88 | 0.87 | 0.56 | 0.53 | 0.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 21.68 | 23.62 | 23.24 | 23.00 | 22.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 21.68 | 23.62 | 23.24 | 23.00 | 22.80 |
| Revenue From Operations / Share (Rs.) | 88.67 | 87.74 | 86.03 | 114.70 | 95.36 |
| PBDIT / Share (Rs.) | 1.91 | 2.55 | 2.09 | 1.80 | 2.46 |
| PBIT / Share (Rs.) | 1.26 | 2.12 | 1.77 | 1.47 | 2.08 |
| PBT / Share (Rs.) | 0.31 | 0.60 | 0.31 | 0.26 | 0.59 |
| Net Profit / Share (Rs.) | 0.23 | 0.44 | 0.24 | 0.20 | 0.44 |
| PBDIT Margin (%) | 2.15 | 2.91 | 2.42 | 1.56 | 2.57 |
| PBIT Margin (%) | 1.42 | 2.41 | 2.05 | 1.27 | 2.17 |
| PBT Margin (%) | 0.36 | 0.68 | 0.37 | 0.23 | 0.62 |
| Net Profit Margin (%) | 0.26 | 0.50 | 0.28 | 0.17 | 0.46 |
| Return on Networth / Equity (%) | 1.10 | 1.88 | 1.03 | 0.87 | 1.93 |
| Return on Capital Employeed (%) | 5.69 | 8.39 | 7.22 | 5.84 | 9.05 |
| Return On Assets (%) | 0.60 | 0.89 | 0.52 | 0.43 | 1.08 |
| Long Term Debt / Equity (X) | 0.01 | 0.06 | 0.05 | 0.08 | 0.00 |
| Total Debt / Equity (X) | 0.46 | 0.80 | 0.71 | 0.86 | 0.73 |
| Asset Turnover Ratio (%) | 2.44 | 1.83 | 1.87 | 2.65 | 2.22 |
| Current Ratio (X) | 1.93 | 1.85 | 1.89 | 2.09 | 2.16 |
| Quick Ratio (X) | 1.27 | 1.14 | 1.16 | 1.42 | 1.44 |
| Inventory Turnover Ratio (X) | 7.70 | 3.72 | 4.74 | 7.82 | 6.82 |
| Interest Coverage Ratio (X) | 2.03 | 1.68 | 1.44 | 1.51 | 1.66 |
| Interest Coverage Ratio (Post Tax) (X) | 1.25 | 1.29 | 1.17 | 1.17 | 1.30 |
| Enterprise Value (Cr.) | 49.65 | 66.52 | 61.28 | 70.59 | 62.18 |
| EV / Net Operating Revenue (X) | 0.21 | 0.43 | 0.41 | 0.35 | 0.37 |
| EV / EBITDA (X) | 10.05 | 15.09 | 17.00 | 22.70 | 14.64 |
| MarketCap / Net Operating Revenue (X) | 0.10 | 0.22 | 0.22 | 0.18 | 0.20 |
| Price / BV (X) | 0.41 | 0.82 | 0.81 | 0.90 | 0.84 |
| Price / Net Operating Revenue (X) | 0.10 | 0.22 | 0.22 | 0.18 | 0.20 |
| EarningsYield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
After reviewing the key financial ratios for Sanginita Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 0.45 (Mar 24) to 0.24, marking a decrease of 0.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 0.45 (Mar 24) to 0.24, marking a decrease of 0.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 3. It has increased from 0.87 (Mar 24) to 0.88, marking an increase of 0.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.68. It has decreased from 23.62 (Mar 24) to 21.68, marking a decrease of 1.94.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.68. It has decreased from 23.62 (Mar 24) to 21.68, marking a decrease of 1.94.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 88.67. It has increased from 87.74 (Mar 24) to 88.67, marking an increase of 0.93.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 2. It has decreased from 2.55 (Mar 24) to 1.91, marking a decrease of 0.64.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.26, marking a decrease of 0.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.60 (Mar 24) to 0.31, marking a decrease of 0.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 2. It has decreased from 0.44 (Mar 24) to 0.23, marking a decrease of 0.21.
- For PBDIT Margin (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 10. It has decreased from 2.91 (Mar 24) to 2.15, marking a decrease of 0.76.
- For PBIT Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 10. It has decreased from 2.41 (Mar 24) to 1.42, marking a decrease of 0.99.
- For PBT Margin (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 10. It has decreased from 0.68 (Mar 24) to 0.36, marking a decrease of 0.32.
- For Net Profit Margin (%), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 5. It has decreased from 0.50 (Mar 24) to 0.26, marking a decrease of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 15. It has decreased from 1.88 (Mar 24) to 1.10, marking a decrease of 0.78.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.69. This value is below the healthy minimum of 10. It has decreased from 8.39 (Mar 24) to 5.69, marking a decrease of 2.70.
- For Return On Assets (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.89 (Mar 24) to 0.60, marking a decrease of 0.29.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.80 (Mar 24) to 0.46, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.44. It has increased from 1.83 (Mar 24) to 2.44, marking an increase of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 1.93, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.14 (Mar 24) to 1.27, marking an increase of 0.13.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.70. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 7.70, marking an increase of 3.98.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 3. It has increased from 1.68 (Mar 24) to 2.03, marking an increase of 0.35.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 3. It has decreased from 1.29 (Mar 24) to 1.25, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 49.65. It has decreased from 66.52 (Mar 24) to 49.65, marking a decrease of 16.87.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.43 (Mar 24) to 0.21, marking a decrease of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 15.09 (Mar 24) to 10.05, marking a decrease of 5.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.10, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.41, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.10, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sanginita Chemicals Ltd:
- Net Profit Margin: 0.26%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.69% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.1% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.25
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 54.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.26%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | No.301, 3rd Floor, Gandhinagar Gujarat 382011 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dineshsinh B Chavada | Chairperson & Managing Director |
| Mr. Vijaysinh D Chavda | Whole Time Director |
| Mr. Faiyazkhan Y Pathan | Independent Director |
| Mr. Jagdishkumar V Thakor | Independent Director |
| Mr. Pramodsinh D Dabhi | Independent Director |
| Mrs. Hansaben D Chavda | Director |
FAQ
What is the intrinsic value of Sanginita Chemicals Ltd?
Sanginita Chemicals Ltd's intrinsic value (as of 06 February 2026) is ₹3.16 which is 72.76% lower the current market price of ₹11.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹30.0 Cr. market cap, FY2025-2026 high/low of ₹14.1/8.46, reserves of ₹30 Cr, and liabilities of ₹102 Cr.
What is the Market Cap of Sanginita Chemicals Ltd?
The Market Cap of Sanginita Chemicals Ltd is 30.0 Cr..
What is the current Stock Price of Sanginita Chemicals Ltd as on 06 February 2026?
The current stock price of Sanginita Chemicals Ltd as on 06 February 2026 is ₹11.6.
What is the High / Low of Sanginita Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sanginita Chemicals Ltd stocks is ₹14.1/8.46.
What is the Stock P/E of Sanginita Chemicals Ltd?
The Stock P/E of Sanginita Chemicals Ltd is .
What is the Book Value of Sanginita Chemicals Ltd?
The Book Value of Sanginita Chemicals Ltd is 21.4.
What is the Dividend Yield of Sanginita Chemicals Ltd?
The Dividend Yield of Sanginita Chemicals Ltd is 0.00 %.
What is the ROCE of Sanginita Chemicals Ltd?
The ROCE of Sanginita Chemicals Ltd is 4.19 %.
What is the ROE of Sanginita Chemicals Ltd?
The ROE of Sanginita Chemicals Ltd is 1.28 %.
What is the Face Value of Sanginita Chemicals Ltd?
The Face Value of Sanginita Chemicals Ltd is 10.0.